Open Journal of Psychiatry

Vol.4 No.3(2014), Paper ID 47667, 7 pages

DOI:10.4236/ojpsych.2014.43026

 

Milnacipran for Attention-Deficit Hyperactivity Disorder Symptoms in Adult Asperger’s Disorder

 

Hirobumi Mashiko, Hiromichi Ishikawa, Shuntaro Itagaki, Yasuko Takanashi, Norihiro Miyashita, Takaaki Okano, Shin-Ichi Niwa, Hirooki Yabe

 

Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan
Department of Neuropsychiatry, School of Medicine, Fukushima Medical University, Fukushima City, Japan

 

Copyright © 2014 Hirobumi Mashiko, Hiromichi Ishikawa, Shuntaro Itagaki, Yasuko Takanashi, Norihiro Miyashita, Takaaki Okano, Shin-Ichi Niwa, Hirooki Yabe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 

How to Cite this Article


Mashiko, H. , Ishikawa, H. , Itagaki, S. , Takanashi, Y. , Miyashita, N. , Okano, T. , Niwa, S. and Yabe, H. (2014) Milnacipran for Attention-Deficit Hyperactivity Disorder Symptoms in Adult Asperger’s Disorder. Open Journal of Psychiatry, 4, 195-201. doi: 10.4236/ojpsych.2014.43026.

Copyright © 2024 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.